EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Purple Biotech's enterprise value is $-1.37 Mil.
Purple Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Purple Biotech's EV-to-Revenue for today is .
The historical rank and industry rank for Purple Biotech's EV-to-Revenue or its related term are showing as below:
During the past 11 years, the highest EV-to-Revenue of Purple Biotech was 212.07. The lowest was -3.00. And the median was 3.79.
PPBT's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.285 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-05-09), Purple Biotech's stock price is $0.5293.
Purple Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, Purple Biotech's PS Ratio for today is .
Purple Biotech EV-to-Revenue Historical Data
The historical data trend for Purple Biotech's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Purple Biotech's EV-to-Revenue
For the Biotechnology subindustry, Purple Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Purple Biotech's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Purple Biotech's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Purple Biotech's EV-to-Revenue falls into.
Purple Biotech's current Enterprise Value is $-1.37 Mil.
Purple Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Purple Biotech's share price for today is $0.5293.
Purple Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Purple Biotech EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Purple Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Purple Biotech (Purple Biotech) Business Description
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PPBT has been successfully added to your 